← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Chrysalis Biotherapeutics, Inc.
Galveston, TX
$15,040,598
Total funding
6
Grants
Funding over time
peak $3M · FY2010–20$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$15,040,598 · 6
By mechanism
N01$6,954,509 · 1
R44$5,789,079 · 1
N44$1,499,927 · 1
R41$300,000 · 1
R43$297,326 · 1
N43$199,757 · 1
Investigators at Chrysalis Biotherapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION$1,984,084
N01 · FY2018 · AI
A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION$1,864,898
N01 · FY2019 · AI
A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION$1,605,375
N01 · FY2017 · AI
SUPPLEMENTAL WORK - SARS-COV-2 PRECLINICAL WORK$1,500,152
N01 · FY2020 · AI
IGF::OT::IGF TP508 MITIGATES RADIOTHERAPY-INDUCED TISSUE DAMAGE - PERIOD OF PERF$1,499,927
N44 · FY2013 · CA
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure$1,000,000
R44 · FY2012 · AI
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2016 · AI
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2018 · AI
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2017 · AI
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure$978,663
R44 · FY2014 · AI
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure$810,416
R44 · FY2013 · AI
Prevention of Allergic Rhinitis with Topical Immunomodulating Antibodies$300,000
R41 · FY2011 · AI
TP508:A New Drug for Mitigating Lethal Effects of Radiation Exposure$297,326
R43 · FY2010 · AI
TAS::75 0849::TAS$199,757
N43 · FY2011 · CA